Pyrazole [3, 4-B] pyridine Raf inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 12, 2013
Grant Date -
Apr 21, 2011
app pub date -
Feb 27, 2009
filing date -
Feb 29, 2008
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully